320 related articles for article (PubMed ID: 15880681)
21. [Clinical features and genetic screening of hereditary hemorrhagic telangiectasia].
Liu C; Lv YX; Yang XD; Huang YH; Luo Y; Yi Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):176-9. PubMed ID: 23568730
[TBL] [Abstract][Full Text] [Related]
22. Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion/duplication analysis.
McDonald J; Damjanovich K; Millson A; Wooderchak W; Chibuk JM; Stevenson DA; Gedge F; Bayrak-Toydemir P
Clin Genet; 2011 Apr; 79(4):335-44. PubMed ID: 21158752
[TBL] [Abstract][Full Text] [Related]
23. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
[TBL] [Abstract][Full Text] [Related]
24. Does the genotype of HHT patients with mutations of the ENG and ACVRL1 gene correlate to different expression levels of the angiogenic factor VEGF?
Sadick H; Hage J; Goessler U; Bran G; Riedel F; Bugert P; Hoermann K
Int J Mol Med; 2008 Nov; 22(5):575-80. PubMed ID: 18949376
[TBL] [Abstract][Full Text] [Related]
25. A novel endoglin mutation in hereditary hemorrhagic telangiectasia type 1: a case report.
Lu Y; Zhu Y; Shi L; Zhen H; Sun Z; Cheng L
Mol Med Rep; 2015 Jul; 12(1):510-2. PubMed ID: 25760803
[TBL] [Abstract][Full Text] [Related]
26. Hereditary hemorrhagic telangiectasia type 1 and 2 mutations in Finland.
Sankelo M; Halme M; Laitinen T; Mattila PS
Acta Otolaryngol; 2008 Nov; 128(11):1238-41. PubMed ID: 18607909
[TBL] [Abstract][Full Text] [Related]
27. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
[TBL] [Abstract][Full Text] [Related]
28. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.
Kitayama K; Ishiguro T; Komiyama M; Morisaki T; Morisaki H; Minase G; Hamanaka K; Miyatake S; Matsumoto N; Kato M; Takahashi T; Yorifuji T
BMC Med Genomics; 2021 Dec; 14(1):288. PubMed ID: 34872578
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
Karlsson T; Cherif H
Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
[TBL] [Abstract][Full Text] [Related]
30. Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family.
Wooderchak W; Gedge F; McDonald M; Krautscheid P; Wang X; Malkiewicz J; Bukjiok CJ; Lewis T; Bayrak-Toydemir P
Clin Genet; 2010 Nov; 78(5):484-9. PubMed ID: 20412114
[TBL] [Abstract][Full Text] [Related]
31. SMAD4 mutations found in unselected HHT patients.
Gallione CJ; Richards JA; Letteboer TG; Rushlow D; Prigoda NL; Leedom TP; Ganguly A; Castells A; Ploos van Amstel JK; Westermann CJ; Pyeritz RE; Marchuk DA
J Med Genet; 2006 Oct; 43(10):793-7. PubMed ID: 16613914
[TBL] [Abstract][Full Text] [Related]
32. [Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].
Major T; Gindele R; Szabó Z; Jóni N; Kis Z; Bora L; Bárdossy P; Rácz T; Karosi T; Bereczky Z
Orv Hetil; 2019 May; 160(18):710-719. PubMed ID: 31030535
[TBL] [Abstract][Full Text] [Related]
33. DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population.
Lenato GM; Lastella P; Di Giacomo MC; Resta N; Suppressa P; Pasculli G; Sabbà C; Guanti G
Hum Mutat; 2006 Feb; 27(2):213-4. PubMed ID: 16429404
[TBL] [Abstract][Full Text] [Related]
34. Association of a polymorphism of the ACVRL1 gene with sporadic arteriovenous malformations of the central nervous system.
Simon M; Franke D; Ludwig M; Aliashkevich AF; Köster G; Oldenburg J; Boström A; Ziegler A; Schramm J
J Neurosurg; 2006 Jun; 104(6):945-9. PubMed ID: 16776339
[TBL] [Abstract][Full Text] [Related]
35. Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients.
Letteboer TG; Zewald RA; Kamping EJ; de Haas G; Mager JJ; Snijder RJ; Lindhout D; Hennekam FA; Westermann CJ; Ploos van Amstel JK
Hum Genet; 2005 Jan; 116(1-2):8-16. PubMed ID: 15517393
[TBL] [Abstract][Full Text] [Related]
36. Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia.
Lee NP; Matevski D; Dumitru D; Piovesan B; Rushlow D; Gallie BL
J Med Genet; 2011 May; 48(5):353-7. PubMed ID: 21415079
[TBL] [Abstract][Full Text] [Related]
37. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
Abdalla SA; Letarte M
J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
[TBL] [Abstract][Full Text] [Related]
38. Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.
Snellings DA; Gallione CJ; Clark DS; Vozoris NT; Faughnan ME; Marchuk DA
Am J Hum Genet; 2019 Nov; 105(5):894-906. PubMed ID: 31630786
[TBL] [Abstract][Full Text] [Related]
39. ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia.
Tørring PM; Kjeldsen AD; Ousager LB; Brusgaard K
Mol Genet Genomic Med; 2018 Jan; 6(1):121-125. PubMed ID: 29243366
[TBL] [Abstract][Full Text] [Related]
40. Multiple sequence variants in hereditary hemorrhagic telangiectasia cases: illustration of complexity in molecular diagnostic interpretation.
McDonald J; Gedge F; Burdette A; Carlisle J; Bukjiok CJ; Fox M; Bayrak-Toydemir P
J Mol Diagn; 2009 Nov; 11(6):569-75. PubMed ID: 19767588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]